General Information of This Linker
Linker ID
LIN0UQZUO
Linker Name
CN119630431A-ADC-46-LINKER
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C29H31N3O10S2
Isosmiles
O=C(N1CCOCCOCCC(N[C@@H](CC(O)=O)C(NCC(O)=O)=O)=O)C(SC2=CC=CC=C2)=C(SC3=CC=CC=C3)C1=O
InChI
InChI=1S/C29H31N3O10S2/c33-22(31-21(17-23(34)35)27(38)30-18-24(36)37)11-13-41-15-16-42-14-12-32-28(39)25(43-19-7-3-1-4-8-19)26(29(32)40)44-20-9-5-2-6-10-20/h1-10,21H,11-18H2,(H,30,38)(H,31,33)(H,34,35)(H,36,37)/t21-/m0/s1
InChIKey
BVJUNUBIISQJRF-NRFANRHFSA-N
Pharmaceutical Properties
Molecule Weight
645.712
Polar area
188.64
Complexity
1249.107977
xlogp Value
1.735
Heavy Count
44
Rot Bonds
19
Hbond acc
10
Hbond Donor
4
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
WO2024043319A1 35 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.038 nM
Positive CEACAM6_#84.7 expression (CEACAM6_#84.7 +++/++)
Method Description
In vitro cytotoxicity of ADCs in AsPC-1 cells.
In Vitro Model Pancreatic ductal adenocarcinoma AsPC-1 cells CVCL_0152
References
Ref 1 Antibody-drug complexes